Management ChangeJun 29, 2026, 05:06 PM
Protara Therapeutics CMO Leonardo Nicacio Resigns
AI Summary
Protara Therapeutics, Inc. announced the resignation of its Chief Medical Officer, Leonardo Viana Nicacio, M.D., effective June 26, 2026. Dr. Nicacio departed to pursue other opportunities. His responsibilities will be absorbed by Carla Beckham, M.D., the company's Lead Medical Director and Head of Clinical Development, with continued oversight from Jacqueline Zummo, Ph.D., Chief Research & Development Officer.
Key Highlights
- Leonardo Viana Nicacio, M.D., Chief Medical Officer, resigned from Protara Therapeutics.
- His resignation was effective as of June 26, 2026.
- Dr. Nicacio resigned to explore other opportunities.
- His duties will be taken over by Carla Beckham, M.D., Lead Medical Director and Head of Clinical Development.
- Oversight of these duties will be provided by Jacqueline Zummo, Ph.D., Chief Research & Development Officer.
Price Impact
More from TARA